Morgan Stanley’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27.9M | Buy |
268,497
+231,141
| +619% | +$24.4M | ﹤0.01% | 2642 |
|
|
2025
Q4 | $3.91M | Buy |
37,356
+87
| +0.2% | +$8.75K | ﹤0.01% | 4368 |
|
|
2025
Q3 | $3.45M | Sell |
37,269
-1,998
| -5% | -$175K | ﹤0.01% | 4428 |
|
|
2025
Q2 | $3.14M | Sell |
39,267
-6,790
| -15% | -$542K | ﹤0.01% | 4415 |
|
|
2025
Q1 | $3.99M | Sell |
46,057
-60,931
| -57% | -$5.19M | ﹤0.01% | 4116 |
|
|
2024
Q4 | $8.84M | Buy |
106,988
+52,377
| +96% | +$4.51M | ﹤0.01% | 3513 |
|
|
2024
Q3 | $4.75M | Sell |
54,611
-12,084
| -18% | -$1.03M | ﹤0.01% | 3992 |
|
|
2024
Q2 | $5.48M | Sell |
66,695
-8,431
| -11% | -$670K | ﹤0.01% | 3802 |
|
|
2024
Q1 | $6.02M | Sell |
75,126
-16,394
| -18% | -$1.27M | ﹤0.01% | 3771 |
|
|
2023
Q4 | $6.96M | Buy |
91,520
+45,152
| +97% | +$3.23M | ﹤0.01% | 4168 |
|
|
2023
Q3 | $3.36M | Sell |
46,368
-46,984
| -50% | -$3.6M | ﹤0.01% | 4022 |
|
|
2023
Q2 | $7.06M | Sell |
93,352
-87,502
| -48% | -$6.68M | ﹤0.01% | 3489 |
|
|
2023
Q1 | $13.7M | Buy |
180,854
+22,023
| +14% | +$1.7M | ﹤0.01% | 2840 |
|
|
2022
Q4 | $12.5M | Buy |
158,831
+18,173
| +13% | +$1.4M | ﹤0.01% | 2849 |
|
|
2022
Q3 | $10M | Buy |
140,658
+11,173
| +9% | +$833K | ﹤0.01% | 2984 |
|
|
2022
Q2 | $9.71M | Buy |
129,485
+84,324
| +187% | +$6.39M | ﹤0.01% | 3097 |
|
|
2022
Q1 | $3.59M | Sell |
45,161
-2,655
| -6% | -$206K | ﹤0.01% | 4033 |
|
|
2021
Q4 | $3.88M | Sell |
47,816
-1,172
| -2% | -$92.6K | ﹤0.01% | 3979 |
|
|
2021
Q3 | $3.79M | Buy |
48,988
+10,573
| +28% | +$853K | ﹤0.01% | 4005 |
|
|
2021
Q2 | $3.09M | Sell |
38,415
-2,532
| -6% | -$201K | ﹤0.01% | 4258 |
|
|
2021
Q1 | $3.23M | Buy |
40,947
+8,692
| +27% | +$678K | ﹤0.01% | 3856 |
|
|
2020
Q4 | $2.3M | Sell |
32,255
-19,902
| -38% | -$1.33M | ﹤0.01% | 4030 |
|
|
2020
Q3 | $3.33M | Sell |
52,157
-95
| -0.2% | -$6.21K | ﹤0.01% | 3135 |
|
|
2020
Q2 | $3.38M | Buy |
52,252
+2,646
| +5% | +$164K | ﹤0.01% | 3069 |
|
|
2020
Q1 | $2.73M | Buy |
49,606
+1,933
| +4% | +$118K | ﹤0.01% | 3070 |
|
|
2019
Q4 | $3.08M | Sell |
47,673
-4,317
| -8% | -$263K | ﹤0.01% | 3679 |
|
|
2019
Q3 | $2.95M | Sell |
51,990
-10,769
| -17% | -$619K | ﹤0.01% | 3439 |
|
|
2019
Q2 | $3.78M | Sell |
62,759
-13,498
| -18% | -$828K | ﹤0.01% | 3216 |
|
|
2019
Q1 | $4.97M | Sell |
76,257
-90,269
| -54% | -$5.93M | ﹤0.01% | 2724 |
|
|
2018
Q4 | $10.4M | Buy |
166,526
+63,078
| +61% | +$4.26M | ﹤0.01% | 2084 |
|
|
2018
Q3 | $7.61M | Buy |
103,448
+26,142
| +34% | +$1.88M | ﹤0.01% | 2708 |
|
|
2018
Q2 | $5.2M | Sell |
77,306
-24,854
| -24% | -$1.6M | ﹤0.01% | 3097 |
|
|
2018
Q1 | $6.38M | Sell |
102,160
-27,092
| -21% | -$1.78M | ﹤0.01% | 2768 |
|
|
2017
Q4 | $8.29M | Sell |
129,252
-281
| -0.2% | -$18K | ﹤0.01% | 2594 |
|
|
2017
Q3 | $8.46M | Sell |
129,533
-6,182
| -5% | -$390K | ﹤0.01% | 2449 |
|
|
2017
Q2 | $8.52M | Sell |
135,715
-19,772
| -13% | -$1.19M | ﹤0.01% | 2328 |
|
|
2017
Q1 | $9.14M | Sell |
155,487
-21,916
| -12% | -$1.28M | ﹤0.01% | 2289 |
|
|
2016
Q4 | $9.94M | Buy |
177,403
+25,405
| +17% | +$1.46M | ﹤0.01% | 2260 |
|
|
2016
Q3 | $9.37M | Sell |
151,998
-2,739
| -2% | -$179K | ﹤0.01% | 2063 |
|
|
2016
Q2 | $9.8M | Sell |
154,737
-12,806
| -8% | -$805K | ﹤0.01% | 1995 |
|
|
2016
Q1 | $10.1M | Sell |
167,543
-351,302
| -68% | -$21.5M | ﹤0.01% | 1861 |
|
|
2015
Q4 | $36.3M | Sell |
518,845
-36,404
| -7% | -$2.58M | 0.01% | 988 |
|
|
2015
Q3 | $36.8M | Sell |
555,249
-17,334
| -3% | -$1.35M | 0.01% | 972 |
|
|
2015
Q2 | $44.9M | Sell |
572,583
-9,116
| -2% | -$710K | 0.02% | 932 |
|
|
2015
Q1 | $44.4M | Buy |
581,699
+1,392
| +0.2% | +$102K | 0.02% | 917 |
|
|
2014
Q4 | $38.6M | Sell |
580,307
-95,759
| -14% | -$6.38M | 0.01% | 1006 |
|
|
2014
Q3 | $43M | Sell |
676,066
-27,532
| -4% | -$1.7M | 0.02% | 900 |
|
|
2014
Q2 | $43M | Sell |
703,598
-77,842
| -10% | -$4.51M | 0.02% | 885 |
|
|
2014
Q1 | $44.3M | Buy |
781,440
+71,188
| +10% | +$4.04M | 0.02% | 812 |
|
|
2013
Q4 | $38M | Buy |
710,252
+59,273
| +9% | +$2.97M | 0.02% | 896 |
|
|
2013
Q3 | $30M | Buy |
650,979
+168,375
| +35% | +$7.68M | 0.01% | 951 |
|
|
2013
Q2 | $20.4M | Buy |
+482,604
| New | +$20.1M | 0.01% | 1166 |
|
Other funds holding PJP
PAM
CI
Morgan Stanley's PJP Position: Q1 2026 in Review
Morgan Stanley increased its Invesco Pharmaceuticals ETF (PJP) stake by 619% in Q1 2026, buying an estimated $24.4M and bringing the position to 268,497 shares worth $27.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2642.
Morgan Stanley first reported a position in PJP in Q2 2013 and has held it in 52 quarters since. The position peaked at $44.9M in Q2 2015. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.
- Morgan Stanley held 268,497 shares of Invesco Pharmaceuticals ETF worth $27.9M as of Q1 2026.
- Morgan Stanley bought 231,141 Invesco Pharmaceuticals ETF shares in Q1 2026, an estimated $24.4M.
- Invesco Pharmaceuticals ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #2642 holding.
- Morgan Stanley first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 52 quarters since.
- Morgan Stanley's Invesco Pharmaceuticals ETF position peaked at $44.9M in Q2 2015.
- 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.